HRP20171431T1 - Terapijska parenteralna primjena krilovog ulja - Google Patents
Terapijska parenteralna primjena krilovog ulja Download PDFInfo
- Publication number
- HRP20171431T1 HRP20171431T1 HRP20171431TT HRP20171431T HRP20171431T1 HR P20171431 T1 HRP20171431 T1 HR P20171431T1 HR P20171431T T HRP20171431T T HR P20171431TT HR P20171431 T HRP20171431 T HR P20171431T HR P20171431 T1 HRP20171431 T1 HR P20171431T1
- Authority
- HR
- Croatia
- Prior art keywords
- intended
- omega
- amount
- accordance
- oil
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Dispersion Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/161,101 US8895074B2 (en) | 2011-06-15 | 2011-06-15 | Therapeutic application of parenteral krill oil |
| EP11179821 | 2011-09-02 | ||
| PCT/IB2012/001156 WO2012172411A1 (en) | 2011-06-15 | 2012-06-13 | Therapeutic application of parenteral krill oil |
| EP12731667.7A EP2720701B1 (en) | 2011-06-15 | 2012-06-13 | Therapeutic application of parenteral krill oil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20171431T1 true HRP20171431T1 (hr) | 2017-12-15 |
Family
ID=46456944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20171431TT HRP20171431T1 (hr) | 2011-06-15 | 2012-06-13 | Terapijska parenteralna primjena krilovog ulja |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP2720701B1 (enExample) |
| JP (1) | JP5864735B2 (enExample) |
| KR (1) | KR101841588B1 (enExample) |
| CN (2) | CN107648268B (enExample) |
| BR (1) | BR112013032224B1 (enExample) |
| CA (1) | CA2838312C (enExample) |
| CY (1) | CY1119417T1 (enExample) |
| DK (1) | DK2720701T3 (enExample) |
| ES (1) | ES2643843T3 (enExample) |
| HR (1) | HRP20171431T1 (enExample) |
| HU (1) | HUE036720T2 (enExample) |
| IL (1) | IL229690A (enExample) |
| LT (1) | LT2720701T (enExample) |
| MX (1) | MX351895B (enExample) |
| PL (1) | PL2720701T3 (enExample) |
| PT (1) | PT2720701T (enExample) |
| RS (1) | RS56394B1 (enExample) |
| RU (1) | RU2625760C2 (enExample) |
| SI (1) | SI2720701T1 (enExample) |
| SM (1) | SMT201700470T1 (enExample) |
| TW (1) | TWI592160B (enExample) |
| WO (1) | WO2012172411A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2993980B1 (en) | 2013-05-10 | 2023-11-01 | Memorial Sloan Kettering Cancer Center | Lipid scavenging in ras cancers |
| GB201402457D0 (en) | 2014-02-12 | 2014-03-26 | Aker Biomarine As | Capsules containing high doses of phospholipids |
| GB201402450D0 (en) | 2014-02-12 | 2014-03-26 | Aker Biomarine As | Liquid phospholipid-containing compositions for preperation of pharmaceuticals |
| GB201407345D0 (en) | 2014-04-25 | 2014-06-11 | Aker Biomarine As | Krill Phospholipid compositions |
| PL3137070T3 (pl) * | 2014-04-30 | 2020-07-13 | Aker Biomarine Antarctic As | Preparaty z oleju z kryla i ich zastosowania |
| EP3232798A1 (en) | 2014-12-19 | 2017-10-25 | Aker Biomarine Antarctic AS | Enhanced omega-3 formulations |
| JP6814148B2 (ja) * | 2015-03-31 | 2021-01-13 | フレゼニウス カービ ドイチュラント ゲーエムベーハー | 非経口投与用のエマルション |
| CN105901740A (zh) * | 2016-04-26 | 2016-08-31 | 济南极源生物科技有限公司 | 一种南极磷虾油可食用营养品 |
| CN118000419A (zh) * | 2017-08-10 | 2024-05-10 | 儿童医疗中心有限公司 | 与包含鱼油和/或ω-3脂肪酸的乳剂有关的方法和组合物 |
| EP3536332A1 (en) * | 2018-03-07 | 2019-09-11 | Athenion AG | Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents |
| KR102451162B1 (ko) * | 2020-09-07 | 2022-10-06 | (주)에스디생명공학 | 효소처리 크릴 오일 추출물을 유효성분으로 포함하는 항염증, 피부 주름개선, 보습 및 피부 재생 촉진용 조성물 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9101642D0 (sv) * | 1991-05-30 | 1991-05-30 | Kabi Pharmacia Ab | Phospholipids |
| JPH08231391A (ja) * | 1995-02-24 | 1996-09-10 | Kanagawa Kagaku Kenkyusho:Kk | 痴呆症状改善薬 |
| ATE497384T1 (de) * | 1997-12-10 | 2011-02-15 | Cyclosporine Therapeutics Ltd | Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen |
| GB0012597D0 (en) * | 2000-05-25 | 2000-07-12 | Astrazeneca Ab | Formulation |
| DK1997498T3 (da) * | 2001-06-18 | 2012-07-30 | Neptune Technologies & Bioressources Inc | Krillekstrakter til forebyggelse og/eller behandling af kardiovaskulære sygdomme |
| US7666447B2 (en) | 2004-10-08 | 2010-02-23 | Pharmanutrients | Compositions including Krill extracts and conjugated linoleic acid and methods of using same |
| CN101321477A (zh) * | 2005-10-07 | 2008-12-10 | 加拿大海洋营养食品有限公司 | 脂肪酸盐及其制备和使用方法 |
| CL2007003283A1 (es) * | 2006-11-16 | 2008-05-23 | Pronova Biopharma Norge As | Proceso para extraer una fraccion casi total de lipidos a partir del krill fresco que comprende reducir el contenido de agua de la materia prima y aislar la fraccion de lipidos; fraccion casi total de lipidos; proceso para separar fosfolipidos; fracc |
| WO2008117062A1 (en) | 2007-03-28 | 2008-10-02 | Aker Biomarine Asa | Bioeffective krill oil compositions |
| JP5443979B2 (ja) * | 2007-05-11 | 2014-03-19 | 備前化成株式会社 | 新規のロイコトリエン受容体アンタゴニスト |
| NO327925B1 (no) * | 2007-06-25 | 2009-10-19 | Pharmalogica As | Anvendelse av kullsyre i drikker omfattende polyumettede fettsyrer (PUFA) for a hindre oksidasjon av fettsyrene. |
| US20090099261A1 (en) * | 2007-09-25 | 2009-04-16 | Isi Brands Inc. | Omega-3 mixtures |
| US20100062057A1 (en) * | 2008-09-10 | 2010-03-11 | Pronova BioPharma Norge AS. | Formulation |
| US20100130619A1 (en) * | 2008-11-24 | 2010-05-27 | Joseph Schwarz | Pharmaceutical composition for parenteral administration of idebenone |
| US8241672B2 (en) | 2009-03-11 | 2012-08-14 | Stable Solutions Llc | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| US20110071090A1 (en) * | 2009-03-11 | 2011-03-24 | Stable Solutions Llc | Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle |
| NO333013B1 (no) * | 2009-07-06 | 2013-02-18 | Smartfish As | Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning. |
| US8609157B2 (en) * | 2009-10-30 | 2013-12-17 | Tharos Ltd. | Solvent-free process for obtaining phospholipids and neutral enriched krill oils |
-
2012
- 2012-06-13 JP JP2014515299A patent/JP5864735B2/ja not_active Expired - Fee Related
- 2012-06-13 CA CA2838312A patent/CA2838312C/en not_active Expired - Fee Related
- 2012-06-13 KR KR1020147001111A patent/KR101841588B1/ko not_active Expired - Fee Related
- 2012-06-13 SI SI201231091T patent/SI2720701T1/sl unknown
- 2012-06-13 HR HRP20171431TT patent/HRP20171431T1/hr unknown
- 2012-06-13 PT PT127316677T patent/PT2720701T/pt unknown
- 2012-06-13 SM SM20170470T patent/SMT201700470T1/it unknown
- 2012-06-13 EP EP12731667.7A patent/EP2720701B1/en active Active
- 2012-06-13 BR BR112013032224-1A patent/BR112013032224B1/pt not_active IP Right Cessation
- 2012-06-13 HU HUE12731667A patent/HUE036720T2/hu unknown
- 2012-06-13 CN CN201710990052.1A patent/CN107648268B/zh not_active Expired - Fee Related
- 2012-06-13 RU RU2014101067A patent/RU2625760C2/ru active
- 2012-06-13 ES ES12731667.7T patent/ES2643843T3/es active Active
- 2012-06-13 MX MX2013014901A patent/MX351895B/es active IP Right Grant
- 2012-06-13 PL PL12731667T patent/PL2720701T3/pl unknown
- 2012-06-13 DK DK12731667.7T patent/DK2720701T3/en active
- 2012-06-13 LT LTEP12731667.7T patent/LT2720701T/lt unknown
- 2012-06-13 CN CN201280028987.7A patent/CN103608023A/zh active Pending
- 2012-06-13 RS RS20170981A patent/RS56394B1/sr unknown
- 2012-06-13 WO PCT/IB2012/001156 patent/WO2012172411A1/en not_active Ceased
- 2012-06-15 TW TW101121508A patent/TWI592160B/zh not_active IP Right Cessation
-
2013
- 2013-11-28 IL IL229690A patent/IL229690A/en active IP Right Grant
-
2017
- 2017-10-04 CY CY20171101030T patent/CY1119417T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI592160B (zh) | 2017-07-21 |
| BR112013032224A2 (pt) | 2016-12-20 |
| EP2720701B1 (en) | 2017-08-09 |
| CA2838312A1 (en) | 2012-12-20 |
| KR20140053957A (ko) | 2014-05-08 |
| JP5864735B2 (ja) | 2016-02-17 |
| SI2720701T1 (sl) | 2017-12-29 |
| RU2014101067A (ru) | 2015-07-20 |
| LT2720701T (lt) | 2017-11-10 |
| MX2013014901A (es) | 2014-07-09 |
| WO2012172411A1 (en) | 2012-12-20 |
| CN107648268A (zh) | 2018-02-02 |
| JP2014517028A (ja) | 2014-07-17 |
| RU2625760C2 (ru) | 2017-07-18 |
| PL2720701T3 (pl) | 2018-01-31 |
| TW201302209A (zh) | 2013-01-16 |
| BR112013032224B1 (pt) | 2021-10-13 |
| SMT201700470T1 (it) | 2018-01-11 |
| CN107648268B (zh) | 2021-06-22 |
| PT2720701T (pt) | 2017-10-23 |
| EP2720701A1 (en) | 2014-04-23 |
| CA2838312C (en) | 2019-01-08 |
| IL229690A0 (en) | 2014-01-30 |
| HUE036720T2 (hu) | 2018-07-30 |
| IL229690A (en) | 2017-01-31 |
| CY1119417T1 (el) | 2018-03-07 |
| KR101841588B1 (ko) | 2018-03-26 |
| DK2720701T3 (en) | 2017-10-30 |
| ES2643843T3 (es) | 2017-11-24 |
| MX351895B (es) | 2017-11-01 |
| CN103608023A (zh) | 2014-02-26 |
| RS56394B1 (sr) | 2017-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20171431T1 (hr) | Terapijska parenteralna primjena krilovog ulja | |
| HRP20200068T1 (hr) | Etilni ester ikozapentaenske kiseline, namijenjen liječenju hipertrigliceridemije | |
| RU2014138996A (ru) | Гормонсодержащая эмульсия | |
| HRP20210309T1 (hr) | Postupci za smanjivanje rizika kardiovaskularnih slučajeva kod pojedinca na statinskoj terapiji uporabom etilestera eikosapentaenoične kiseline | |
| US8663704B2 (en) | Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (LDL) per-oxidation in humans | |
| WO2010104575A3 (en) | Omega-3 enriched fish oil-in-water parenteral nutrition emulsions | |
| HRP20210686T1 (hr) | Pripravci i postupci za liječenje moždanog udara kod subjekta na istodobnoj terapiji statinom | |
| US20070122452A1 (en) | Fat composition | |
| JP2014517028A5 (enExample) | ||
| HRP20161272T4 (hr) | Učinci metaboličkog utiskivanja specifično dizajnirane lipidne komponente | |
| RU2017118984A (ru) | Молочная смесь, содержащая олигосахариды грудного молока, полиненасыщенные жирные кислоты, нуклеотиды и лютеин | |
| FI3664628T3 (fi) | Kalaöljyä ja/tai omega-3-rasvahappoja käsittäviä emulsioita koskevia menetelmiä ja koostumuksia | |
| WO2011137160A3 (en) | Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans | |
| JP2020530464A5 (enExample) | ||
| RU2016129079A (ru) | Композиции омега-3 жирных кислот для лечения заболеваний, вызывающих поражение нервной системы | |
| WO2006111633A3 (fr) | Utilisation de la lecithine comme medicament dans le traitement du psoriasis | |
| Saito et al. | Characteristics of lipid composition differences between cultured and wild ayu (Plecoglossus altivelis) | |
| JP2012508791A5 (enExample) | ||
| RU2016116835A (ru) | Способы и композиции для улучшения функции почек | |
| JP6949670B2 (ja) | 難溶性物質を含有する経口摂取用組成物、難溶性物質の消化管吸収性の向上方法及び難溶性物質を含有する水中油型乳化物の胃内での乳化安定化方法 | |
| CA2943000A1 (en) | Homogeneous formulation comprising omega-3 polyunsaturated fatty acid and resveratrol for oral administration | |
| JP6519875B2 (ja) | 改良された魚油ベースのオメガ３補助食品 | |
| JP2017536367A5 (enExample) | ||
| WO2018066394A1 (ja) | 筋肉を柔軟にするための組成物 | |
| CN110139645A (zh) | 用于预防和/或治疗恶病质的ω-3脂肪酸组合物 |